MiNK Therapeutics logo

MiNK Therapeutics

INKT | NASDAQ
Chart Builder DCF Calculator
$9.35
+$0.01 (+0.11%)
At close: Nov 16, 2026, 4:00 PM ET
$9.26
-$0.09 (-0.96%)
After-hours: Nov 16, 2026, 7:30 PM ET
+0.11%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
38.2
+3.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #576/1021 (Top 56%)

Key Statistics

Market Data

Market Cap $48M
1D Range
9.08 9.76
52W Range
8.56 14.21

Valuation (TTM)

PE -4.17
PB -2.95
EV/EBITDA -3.48

Valuation (NTM)

Forward PE N/A
Forward PEG 0.17
Price Target $35.00
Loading financial charts...

Profile

MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natur...

Sector Healthcare
Industry Biotechnology
Employees 15
IPO Date Oct 15, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 11, 2026
EPS
-$0.5
Beat +24.24%
REV
$200K
Beat +166.67%
Next Earnings
Mar 23, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$35.00
Upside
+274.33%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.